至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

Identification of Filamin-A and -B as potential biomarkers for prostate cancer.

Future Sci OA. 2017; 
NarainNiven R,DiersAnne R,LeeArleide,LaoSocheata,ChanJoyce Y,SchofieldSally,AndreaziJoe,Ouro-DjoboRakibou,JimenezJoaquin J,FrissTracey,TannaNikunj,DalviAditee,WangSihe,BunchDustin,SunYezhou,WuWenfang,ThapaKhampaseuth,GestaStephane,RodriguesLeonardo O,AkmaevViatcheslav R,VishnudasVivek K,SarangarajanRangapr
Products/Services Used Details Operation
Recombinant Proteins … During the assay, 50 µl of assay diluent was added to all wells followed by 100 µl of standard, control and sample per well. The standard was full-length recombinant human protein (Genscript, NJ, USA) in the range of 0.156–10 pM … Get A Quote

摘要

A novel strategy for prostate cancer (PrCa) biomarker discovery is described.

关键词

Bayesian network learning,FLNA,FLNB,KRT19,biomarkers,prostate ca